Congress Park Capital Llc Activity Analysis: Q2 2026 Portfolio Changes
Congress Park Capital Llc made significant adjustments to its portfolio in Q2 2026, highlighting substantial purchases and sales across various sectors.
Based on the latest filing data from Congress Park Capital Llc, this quarter (ending June 30, 2026) saw considerable activity within its investment strategy. The fund manager demonstrated a proactive approach to portfolio management with notable shifts in holdings.
Key areas of focus appeared to be fixed income securities and specific equity positions. Among the most significant purchases was the ETF holding JFR (NUVEEN Floating Rate Income Fund), which increased its portfolio allocation from 7.12% to 7.2%. Similarly, another fixed income fund, QQQM, saw a substantial rise in its position due to an increase of over 15%, indicating strong confidence in the exchange-traded fund space.
Other notable additions included PULS, which experienced a significant boost, and NVG (NUVEEN AMT Free Mun CR Inc F) also showed considerable growth. The fund manager appears to be actively allocating capital towards high-yielding fixed income vehicles.
In contrast, the investor was notably active in exiting positions or reducing exposure. A major sale occurred with HRTX (Heron Therapeutics), where they sold their entire stake, resulting in a -50% change and effectively removing it from the portfolio.
Additionally, holdings like TTD (The Trade Desk) saw reductions of nearly 31%, while INTC experienced a -46% change. This suggests strategic decisions to scale back technology stock exposure, possibly due to valuation concerns or shifting focus.
The overall portfolio turnover rate was high, reflecting active management strategies focused on maximizing returns through targeted buying and selling activities during this period.